BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33942583)

  • 1. Updates on Therapeutic Alternatives for Genitourinary Syndrome of Menopause: Hormonal and Non-Hormonal Managements.
    Shim S; Park KM; Chung YJ; Kim MR
    J Menopausal Med; 2021 Apr; 27(1):1-7. PubMed ID: 33942583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
    The NAMS 2020 GSM Position Statement Editorial Panel
    Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.
    Crean-Tate KK; Faubion SS; Pederson HJ; Vencill JA; Batur P
    Am J Obstet Gynecol; 2020 Feb; 222(2):103-113. PubMed ID: 31473229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Hocké C; Diaz M; Bernard V; Frantz S; Lambert M; Mathieu C; Grellety-Cherbero M
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):394-413. PubMed ID: 33757926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause.
    Wurz GT; Kao CJ; DeGregorio MW
    Clin Interv Aging; 2014; 9():1939-50. PubMed ID: 25419123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
    Lubián López DM
    World J Clin Oncol; 2022 Feb; 13(2):71-100. PubMed ID: 35316932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data.
    Angelou K; Grigoriadis T; Diakosavvas M; Zacharakis D; Athanasiou S
    Cureus; 2020 Apr; 12(4):e7586. PubMed ID: 32399320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the genitourinary syndrome of menopause.
    Palacios S; Mejía A; Neyro JL
    Climacteric; 2015; 18 Suppl 1():23-9. PubMed ID: 26366797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
    Wallace SL; St Martin B; Lee K; Sokol ER
    Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genitourinary Syndrome of Menopause.
    Shifren JL
    Clin Obstet Gynecol; 2018 Sep; 61(3):508-516. PubMed ID: 29787390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy.
    Sussman TA; Kruse ML; Thacker HL; Abraham J
    J Oncol Pract; 2019 Jul; 15(7):363-370. PubMed ID: 31291563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on drugs for the treatment of menopausal symptoms.
    Palacios S; Mejias A
    Expert Opin Pharmacother; 2015; 16(16):2437-47. PubMed ID: 26395223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update.
    Merlino L; D'Ovidio G; Matys V; Piccioni MG; Porpora MG; Senatori R; Viscardi MF; Vitale A; Della Rocca C; On Behalf Of Policlinico Umberto I Collaborators
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety.
    Potter N; Panay N
    Climacteric; 2021 Feb; 24(1):19-24. PubMed ID: 32990054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female Pelvic Conditions: Genitourinary Syndrome of Menopause.
    Brady PH; Gin GT; Rosenblum E; Wilkinson LD
    FP Essent; 2022 Apr; 515():32-42. PubMed ID: 35420405
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaginal estrogens for the treatment of dyspareunia.
    Krychman ML
    J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.
    Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L
    Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone Therapy and Other Treatments for Symptoms of Menopause.
    Hill DA; Crider M; Hill SR
    Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Treatment of Genitourinary Syndrome of Menopause.
    Hodges AL; Holland AC; Dehn B; Pace DT
    Nurs Womens Health; 2018 Oct; 22(5):423-430. PubMed ID: 30170002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.